<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Mon, 15 Dec 2025 11:01:02 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback</title><link>https://www.benzinga.com/m-a/25/12/49392251/cencora-strikes-5-billion-oneoncology-deal-pauses-stock-buyback</link><image_url>https://cdn.benzinga.com/files/images/story/2025/12/15/Cencora-Photo-by-JHVEPhoto-via-Shutterst.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Cencora agrees to buy a majority stake in OneOncology for about $5 billion, pauses buybacks, and reiterates fiscal 2026 sales and EPS guidance. read m...</description><pubDate>Mon, 15 Dec 2025 14:09:50 GMT</pubDate></item><item><title>Cathie Wood's 2026 Playbook: BTC Leads Crypto Portfolio, Trimming TSLA  To 'Rebalance'</title><link>https://www.benzinga.com/crypto/cryptocurrency/25/12/49392219/cathie-woods-2026-playbook-btc-leads-crypto-portfolio-trimming-tsla-to-rebalance</link><image_url>https://cdn.benzinga.com/files/images/story/2025/12/15/Cathie-Wood-Doubles-Down-On-This-Bitcoin.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>ARK Invest CEO Cathie Wood said ARK is undergoing a portfolio rebalancing beyond the "Mag 7" in order to align with the next wave of innovation . read...</description><pubDate>Mon, 15 Dec 2025 14:07:43 GMT</pubDate></item><item><title>Milestone Wins FDA Approval For First Self-Use Nasal Spray For Sudden Fast Heartbeats</title><link>https://www.benzinga.com/news/fda/25/12/49391801/milestone-wins-fda-approval-for-first-self-use-nasal-spray-for-sudden-fast-heartbeats</link><image_url>https://cdn.benzinga.com/files/images/story/2025/12/15/Bought-This-Nasal-Spray--Stop-Using-It-N.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for PSVT in 30 years. read mor...</description><pubDate>Mon, 15 Dec 2025 14:02:00 GMT</pubDate></item><item><title>A Look at Duluth Holdings's Upcoming Earnings Report</title><link>https://www.benzinga.com/insights/earnings/25/12/49391760/a-look-at-duluth-holdingss-upcoming-earnings-report</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_preview_6.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Mon, 15 Dec 2025 14:01:11 GMT</pubDate></item><item><title>A Glimpse of OrganiGram Holdings's Earnings Potential</title><link>https://www.benzinga.com/insights/earnings/25/12/49391719/a-glimpse-of-organigram-holdingss-earnings-potential</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_preview_12.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Mon, 15 Dec 2025 14:00:58 GMT</pubDate></item></channel></rss>